Related references
Note: Only part of the references are listed.PGRS domain structures: Doomed to sail the mycomembrane
Rita Berisio et al.
PLOS PATHOGENS (2022)
PE_PGRS33, an Important Virulence Factor of Mycobacterium tuberculosis and Potential Target of Host Humoral Immune Response
Eliza Kramarska et al.
CELLS (2021)
Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants
Ana Rita Franco et al.
CELLS (2021)
Thinking Outside the Bug: Targeting Outer Membrane Proteins for Burkholderia Vaccines
Megan E. Grund et al.
CELLS (2021)
Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation
Virgil Schijns et al.
PHARMACEUTICS (2021)
Lessons from Bacillus Calmette-Guerin: Harnessing Trained Immunity for Vaccine Development
Samuel T. Pasco et al.
CELLS (2020)
Understanding Pseudomonas aeruginosa-Host Interactions: The Ongoing Quest for an Efficacious Vaccine
Maite Sainz-Mejias et al.
CELLS (2020)
Current Advances in Burkholderia Vaccines Development
Guanbo Wang et al.
CELLS (2020)
Recent Advances in the Development of Protein- and Peptide-Based Subunit Vaccines against Tuberculosis
Chiara Bellini et al.
CELLS (2020)
Current Status on Therapeutic Molecules Targeting Siglec Receptors
Maria Pia Lenza et al.
CELLS (2020)
Advances and Prospects in Vaccine Development against Enterococci
Ermioni Kalfopoulou et al.
CELLS (2020)